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SUMMARY 
 
This PhD thesis is mainly focused on the key role of extracellular matrix in skin tissue 
engineering. In the first part I presented three dimensional structures derived through 
the physiological cell secretion of extracellular matrix (ECM), that may be a bioinspired 
scaffold. I performed a biological characterization of cell-assembled ECMs from three 
different sub-populations of fibroblasts found in human skin; papillary fibroblasts (Pfi), 
reticular fibroblasts (Rfi), and dermal papilla fibroblasts (DPfi).                      
Specifically, fibroblast sub-populations were cultured with ascorbic acid to promote 
cell-assembled matrix production for 10 days. Subsequently, cells were removed and 
the remaining matrices were characterized. I found that the ECM assembled by Pfi 
exhibited randomly oriented fibers, associated with highest interfibrillar space, 
reflecting ECM characteristics which are physiologically present within the papillary 
dermis. Mass spectrometry followed by validation with immunofluorescence analysis 
showed that THROMBOSPONDIN (TSP1) is preferentially expressed within the DPfi 
derived matrix. Additionally, in another experiment, keratinocytes were seeded on the 
top of cell depleted ECMs to generate epidermal only skin constructs.                                         
I found that epidermal constructs grown on DPfi or Pfi matrices exhibited normal 
basement membrane formation, while Rfi matrices were unable to support membrane 
formation. For this reason, inspiration should be taken from these different ECMs, to 
improve the design of therapeutic biomaterials in skin engineering applications. 
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In the second part, I focused on human decellularized dermal matrices, due to their 
ability to reduce numerous side effects related to hernia repair. However, only animal 
studies investigated the biological interaction post-implant of human decellularized 
matrices for soft tissue repair. Thus, the aims of this second part were to show the 
clinical results after the application of human decellularized matrix produced by 
Regional Skin Bank in patients suffering from abdominal hernia and to evaluate the 
morphologic response one year post implant, through morphological analysis of biopsy 
specimens. Overall, clinical results showed that all the patients revealed a well 
tolerability of human decellularized dermal matrix and a normal wound healing was 
also identified in all the damage areas. Follow up after 6 months reported no signs of 
dermis rejection and that none of the patients was positive to serological tests.       
Moreover, histological and ultrastructural results of post-implant biopsy specimens 
showed a perfect cellular repopulation, neo-angiogenesis, minimal inflammatory 
response and a well-organized collagen matrix in all biopsies investigated.                              
Thus, this scaffold can be considered a safe and useful product to treat large abdominal 
defects, characterized by minor complications and simplicity to be implanted.   
. 
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1. INTRODUCTION 
 
1.1 Morpho-functional aspects of the skin 
Skin is the largest and one of the most complex organ in the human body, that consists 
of a multi-layered structure comprising of an underlying supporting dermis and 
functional epithelium at the skin surface. In particular, the epidermis is a highly 
specialized epithelium that has evolved to perform multiple essential protective 
functions, for this reason skin cellular components must remain dynamic to allow tissue 
regeneration and response to cutaneous insults [1]. 
1.1.1 Functions of the epidermis 
The skin is highly specialized because it provides a barrier function through the 
prevention of water loss, the resistance to mechanical stimuli and the protection against 
physical, chemical and/or biological agents such as temperature, light, chemicals, toxins 
and micro-organisms. In addition to the first function, it plays a role in sensation, 
thermoregulation, excretion, absorption, pigmentation and innate/acquired immunity. 
When this barrier is disrupted due to any cause- surgery, ulcers, burns, neoplasms or 
traumas- the functions of the skin are no longer adequately performed. Therefore, it is 
crucial to restore the integrity of the skin as soon as possible [2]. 
1.1.2 Heterogeneity of skin cells 
Within each layer of the skin there are multiple cells with different functions which 
contribute to tissue homeostasis. The most abundant cell type within the epidermis are 
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the keratinocytes; these differentiate and stratify towards the skin surface equipping skin 
with its barrier function. Specifically, it consists of five layers where stratum basale, the 
deepest layer adjacent to the basal lamina, contains the dividing cells. The other layers 
are named stratum spinosum, stratum granulosum, stratum lucidum and stratum 
corneum (Figure 1). Moreover, the epidermis also contains melanocytes (pigment cells), 
Merkel’s cells (sensory cells) and immature dendritic cells known as Langherhans cells 
(immunological cells). 
 
Figure 1: Drawing of normal human epidermis showing the different layers [3]. 
 
The dermis is a highly specialized and dynamic tissue organized in two main layers.                           
Papillary dermis is the superficial portion of the dermis that lies immediately beneath 
the epidermis and contains the rete ridges. It is demarcated from the underlying reticular 
dermis by a vascular plexus and below rests the hypodermis. The deeper portion of the 
dermis, reticular dermis, is mainly responsible for anchoring of skin appendages (i.e. 
hair, erector-pili muscles, sebaceous glands, and sweat glands) but also gives strength to 
the dermal layer [2].  
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Within the dermis there are actually several types of skin fibroblasts (Figure 2), whose 
primary role is to secrete components of the extracellular matrix (ECM), which can be 
defined by their spatial location [4], and exist as morphologically and functionally-
heterogeneous sub-populations [5]. For example, the fibroblast population within the 
dermal layer adjacent to the basement membrane and epidermis known as the papillary 
dermis are called papillary fibroblasts (Pfi). These are distinct from those residing 
within the lower reticular dermis, which are termed reticular fibroblasts (Rfi) [6].                     
In hairy skin there are also fibroblasts associated with the hair follicle, located in the 
dermal papilla and the connective tissue sheath [7]. Dermal papilla fibroblasts (DPfi) 
have specialized signalling properties required for hair follicle morphogenesis and 
coordination of hair growth [8]. These dermal papilla fibroblasts are also derived from 
the upper (papillary) fibroblasts during skin development (Figure 3). By postnatal day 2 
in mouse skin, these three fibroblast populations are committed to their fate, and they 
contribute to the composition of the skin dermis.  
 
Figure 2: Heterogeneity of cells in skin dermis [9]. 
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Figure 3: Three fibroblast lineages derived from a common cell progenitor dermis [9] 
 
1.1.3 Dermal fibroblasts as the main cell type responsible for extracellular 
matrices synthesis  
Dermal fibroblasts are a key component of skin; they not only produce and organize the 
extracellular matrix (ECM) of the dermis but they also interact with each other and 
other cell types, playing a pivotal role in regulating skin physiology.                                
Various studies have demonstrated that ECMs produced by Pfi and Rfi within the 
interfollicular dermis are distinct with regard to their composition and architecture [5].                                             
Firstly, Pfi in the upper dermis secrete ECM which is constituted of thin, poorly-
organized collagen fiber bundles, while thick well-organized collagen bundles are 
characteristic within the lower dermis which is produced by resident Rfi.                               
The papillary dermis also has a higher ratio of collagen type-III to I, and higher levels of 
decorin. By contrast, versican is more extensively expressed in elastic fibers of the 
reticular dermis [10].  
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In addition, the non-fibrillar collagen types XII and XVI, along with tenascin-C, are 
characteristically found in the papillary dermis; whereas, collagen type IV and tenascin-
X are primarily restricted to the reticular dermis [11, 12]. Finally the dermal papilla is 
also rich in interstitial collagens such as type I and type III, in addition to fibrillar matrix 
proteins such as fibronectin and glycoproteins such as thrombospondin [13].  
1.1.4 Extracellular matrix (ECMs) composition 
The extracellular matrix can be considered as a dense and complex network of 
macromolecules with a well-defined and specific biomechanical properties, which 
regulates cell functions such as growth, differentiation and survival. Cell-ECM adhesion 
occurs due to integrin receptors placed on the cell membranes, which transmit signals 
that allow cells to adapt to the surrounding microenvironment. Furthermore, the ECMs 
release a series of growth factors that have a role in the regulation of different cell 
functions [14]. 
The extracellular matrix components can be divided into: fiber forming structural 
molecules; non fiber forming structural molecules and matricellular proteins that 
modify cell-matrix interaction (Figure 4) [15]. 
 
Figure 4: ECM composition of normal skin [16]. 
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Fiber-forming molecules provide a structure to the ECM by creating a complex three-
dimensional framework of rigid proteins. In particular, collagen is the most abundant 
fiber-forming protein, which comprises 77% of dry weight of human skin [17]. Other 
fiber-forming proteins include fibrin, fibronectin, vitronectin, elastin and fibrillin [18]. 
In contrast, nonfiber-forming structural molecules, mostly proteoglycans and GAGs, fill 
the majority of the tissue’s interstitial space. The most abundant proteoglycans in the 
skin include hyaluronan (HA), decorin, versican and dermatopontin. Their functions are 
hydratation, buffering and force dispersions within tissues, due to their negatively 
charged and hydrophilic nature [19]. Also present in the ECM are the matricellular 
proteins, a group of secreted local proteins that interact in autocrine or paracrine              
cell-matrix signaling. They include osteopontin, secreted protein, acid and rich in 
cysteine (SPARC), tenascin-C, fibulins and the CCN family [20]. 
1.2 Regeneration ability of the skin: wound healing process 
Skin healing requires complex interactions between keratinocytes, fibroblasts, ECM and 
stem cell populations within the basal epidermis, the appendages and underlying 
mesenchyme in order to repair injured tissues. This involves several cellular activities 
such as synthesis of collagen and other matrix components, phagocytosis, chemotaxis, 
and mitogenesis. Under normal conditions, the wound healing process correlates well 
with the appearance of different cell types in various phases of the wound healing 
process. Four distinct, but overlapping, phases characterize this process: Haemostasis, 
Inflammation, Proliferation, and Remodelling (Figure 5) [21]. 
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Figure 5: Stages of cutaneous wound healing [22].  
1.2.1 Role of different fibroblast populations in wound healing 
The functional heterogeneity of fibroblasts is not only important for skin homeostasis 
but also for wound healing. Some studies showed that the first wave of dermal repair is 
mediated by reticular dermis and hypodermis, which are not able of inducing hair 
follicles. These lower lineage fibroblasts express myofibroblast markers such as α-SMA 
and secrete large amounts of ECM proteins such as collagen, characteristics of fibrosis 
[9]. In contrast, upper dermal fibroblasts are recruited during sub-sequent wound re-
epithelisation and can induce hair follicle formation. It is well demonstrated that the 
activation of Wnt pathway induces formation of new hair follicles, fibroblast 
proliferation and dermal ECM remodelling [6]. To understand fibroblast behavior 
within the skin is important, especially in the context of wounding, if we want to 
successfully modulate this process.  
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1.2.2 Extracellular matrix (ECMs) influences in wound healing 
The ECM remodeling is the latter of a dynamic series of physiological events, which 
happen when a cutaneous injury occurs. During wound healing, ECM proteins are 
degraded by proteolytic enzymes, inducing local release of growth factors such as 
fibroblast growth factors, TGF-b, vascular endothelial growth factor, epidermal growth 
factor, and bone morphogenetic proteins from their insoluble anchorage, consisting of 
fibronectin, collagens, proteoglycans, heparin and heparin sulphate. In addition, recent 
studies also demonstrate that ECM proteins are key components in shaping the stem cell 
niche to maintain stem cell homeostasis and to direct lineage commitment  [23]. ECM 
composition in the dermis alters after wound healing. This involves that the normal 
matrix is gradually replaced by a denser matrix composed mainly of collagen.                            
Basically, the most significant difference between normal tissue and scar tissue seems to 
be the orientation of the fibrous matrix [24]. In human scars, the collagen forms cross-
links to align in a single direction parallel to the skin, and there is larger fiber size. 
During the early stages of granulation tissue formation, myofibroblasts deposit collagen 
III, which plays a role in fibrillogenesis and determines the fibril diameter of collagen I 
[25]. Eventually myofibroblasts become surrounded by fibrillar collagen which causes 
arrest in G1 phase of their cycle and a reduction in their ability to adhere to ECM due to 
the disassembly of cellular focal adhesions [26]. For these reasons targeting components 
of the ECM during wound repair provides an attractive approach to avoid abnormal 
scars. 
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1.3 Skin regeneration in vitro: tissue engineering 
The role of Skin Tissue Engineering in the field of Regenerative Medicine has been the 
topic of substantial research over the past three decades. Specifically, Skin Tissue 
Engineering is a multidisciplinary research area based on the understanding of skin 
structure, skin mechanics and tissue formation to induce new functional tissues.                     
Three main pillars of tissue engineering were  identified (Figure 6): a scaffold provides 
a structure for tissue growth, while cells produce the desired extracellular matrix under 
different signals able to affect their growth and phenotype [27].  
 
 
Figure 6: Scheme of the three pillars of tissue engineering. To bring tissue engineering into 
reality, it is crucial to  combine the three [27]. 
 
 
Injured skin can normally promote self-healing thanks to the presence of basal layer 
epidermal stem cells. However in deep injuries, negative regulation of wound healing 
process may lead to the formation of chronic wounds [28]. These non-healing wounds 
account for 2-4% of the health care budget in industrialized counties, with 1% of the 
population affected by such a wound at any time. For these reasons, development of 
effective treatments is a major unmet medical need [29]. The gold standard treatment 
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for these wounds such as burns was a split thickness autograft, taken from an uninjured 
donor site on the patient. Nevertheless they were often limited by the poor availability 
of healthy tissues [30]. In these cases, clinical application of tissue engineered skin 
substitutes is the best strategy to overcome the problems related to autograft.                       
Indeed there are a number of biological products available on the market which promote 
healing, and have been developed combining primary skin cells together with 
biomaterials.  
The development of artificial materials or skin grafts grown in the laboratory for skin 
replacement has been an area of particular interest over the past two decades.                            
In deep wounds, an ‘ideal’ skin substitute would provide immediate replacement of both 
epidermis and dermis layers. Therefore, the ideal skin substitute is nontoxic, has little or 
no antigenicity, is immunologically compatible, and does not transmit disease.                       
 In addition, it is conformable to irregular wound surfaces, flexible and durable, closes 
the wound immediately and it is bio-absorbable. Finally it facilitates early motion; and 
provides coverage of vessels, tendons, and nerves to prevent desiccation [31].  
1.3.1 Products used for treatment of wounds 
There are a number of biological products available on the market which promote 
healing. Early studies carried out by  Rheinwald & Green (1975),  and Yannas & Burke 
(1980) formed the basis for the development of future skin replacements [32].  
Depending on their composition, both synthetic and biological skin substitutes can be 
divided into dermal, epidermal or dermo-epidermal replacements (Figure 7) [28].                            
In particular, there are a small number of bioengineered skin products that replace both 
the epidermis and dermal part of the skin, and one such example is Apligraf®, which is 
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composed of neonate-derived fibroblasts cultured in a bovine collagen matrix, over 
which neonate-derived keratinocytes are seeded to produce a stratified epidermis [33]. 
 In recent years, a group of biological scaffolds comprised of ECMs which are used 
solely as a dermal replacement have gained increasing interest. Their main feature is to 
maintain their own three-dimensional structure for a minimum of three weeks to allow 
in-growth of blood vessels and fibroblasts, as well as coverage by epithelial cells.                   
One of these is Integra®, a dermal regeneration template composed of a layer of bovine 
tendon collagen type I matrix and shark chondroitine-6-sulfate juxtaposed against a 
silicone layer that acts as a temporary pseudo-epidermis [34].                    
Despite the success of Integra, there are some limitations. An alternative to this is 
MatriDerm®, which is an engineered dermal template specially developed to provide a 
one-step grafting procedure. Matriderm® is a scaffold consisting of a native bovine type 
I, III and V collagen fibre template incorporating elastin hydrolysate that is converted 
into native host collagen within weeks following application [35].                                                
In addition to engineered scaffolds, human decellularized dermal matrices (HDM)  from 
cadaveric donors is now becoming more popular as a scaffold for use after injury [36]. 
Also, decellularized skin dermis from cadaveric donor is now becoming more popular 
as a scaffold. The common feature of all these dermal scaffolds is that the native 
collagen fibres form a scaffold that guides fibroblasts and possibly other cells toward 
dermal regeneration, while the presence of elastin particles in the collagen matrix 
diminishes the formation of granulation tissue in the early phase of wound healing.                                      
As a result, a high-quality neodermis with randomly organised collagen bundles is 
regenerated. 
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Figure 7: Schematic representation of skin substitutes’ preparation [32]. 
 
1.4 Human Decellularized Dermal Matrix (HDM) produced by Regional 
Skin Bank  
Nowadays interest is increasing for human decellularized scaffolds, from human 
cadaveric donors obtained through decellularization processes of dermis or fascia lata, 
for their ability to favor the healing and cell infiltration after transplantation, with no 
sign of rejection [37]. These human decellularized matrices are classified as human 
tissues for transplantation and each Country has to follow National Regulatory 
Transplantation Center rules for the control of human-derived tissue transplants [38].  
In 2008, Emilia-Romagna Regional (RER) Skin Bank of Bufalini Hospital in Cesena in 
collaboration with Rizzoli Orthopedic Institute in Bologna, produced a cell-free 
scaffold, totally biocompatible and safe starting from skin of cadaveric donor, patenting 
a decellularization method able to remove cellular components from dermal tissue 
(Figure 8). This scaffold has the potential to interact with the surrounding host tissues, 
maintaining biomechanical strength and biochemical components [36]. 
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Figure 8: Human decellularized dermis (HDM) produced by RER Skin Bank. (A) Gross 
anatomy of HDM after the patented decellularization procedure. (B) Histological staining of 
HDM shows intact collagen fibers and bundles with no cellular materials (H&E, original 
magnification 20x). 
 
Specifically, from 2008 to 2010, human dermis was taken from the backs of 57 multi-
organ and/or multi-tissue donors following national rules on harvesting, processing and 
distributing tissues for transplantation (CNT 09/2016), and decellularized at the Skin 
Bank. Firstly, in sterile conditions, using an electric dermatome, the epidermis was 
separated from the dermis trunk area and discarded, then 10–20 cm2 dermis samples 
were dissected. The dermis grafts were then rinsed with 0.9% NaCl solution and stored 
in this solution for transport (at 2–4 °C) to the treatment station (< 12 h), where they 
were aseptically submitted to a chemical and physical treatment of decellularization.                    
Finally, the dermis was submitted to irradiation with ɤ-rays (100Gy) and stored in 
nitrogen vapor at 180 °C to 190 °C. Membrane cellularity, morphology, bioactivity, 
biomechanical properties and in vivo biocompatibility were assessed before starting 
with the clinical applications of HDM with the approval of the Hospital Ethical 
Committee.  
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1.4.1 Clinical applications of Human Decellularized Dermal Matrix (HDM) 
Human Decellularized Dermal Matrices (HDMs) are currently applied in different 
clinical fields such as  orthopedic surgeries, dental and craniomaxillofacial repairs, soft 
tissue reconstruction, and wound healing [39]. Orthopedic surgeons commonly use 
HDMs in soft tissue repair procedures to provide additional biomechanical strength and 
improve healing for rotator cuff repairs, especially for large and massive tears [40, 41]. 
In addition, HDM is applied to augment Achilles tendon for increased biomechanical 
strength [42]. HDM is also able to facilitate bone regeneration [43] and soft tissue 
alveolar ridge augmentation [44] after a tooth extraction, which usually requires 
immediate ridge augmentation to prevent further resorption, affecting the placement of 
dental implants. Another important clinical application is the treatment of acute and 
chronic wounds. In particular non-healing, diabetic ulcers of the lower limbs can be 
treated with an HDM to achieve complete healing and integration while avoiding 
second site morbidity [45]. Burns treatment has also achieved good outcomes with 
reduced scarring, revascularization and recellularization [46].                                            
Finally, soft tissue reconstruction procedures of the breast and abdominal wall defects 
commonly utilize HDMs.  
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1.5 Abdominal Wall Defects and common treatments  
Abdominal wall defects are unusual abdomen openings and can be caused by trauma, 
burns, treatment of abdominal compartment syndrome and resection of abdominal 
tumors [47]. Although these defects result as one of the most common surgical 
procedures performed every year, they still lead to high mortality rate and represent a 
major challenge for plastic and reconstructive surgeons. Different methods for the repair 
of abdominal wall defects have been described including the use of autogenous fascial 
flaps as well as prosthetic implantable materials [48-50]. In particular, the implantation 
of synthetic biocompatible materials generally allowed a decreased recurrence rate of 
incisional hernia due to their high tensile strength and reconstructive abilities [51-53]. 
However, several side effects may be related to the implantation of synthetic 
biomaterials, including immunological reaction, bowel adhesions, fistula formation, 
surgical site infections or mesh extrusion [54]. In order to avoid these complications, in 
recent decades several biological scaffolds have been designed for abdominal wall 
defects repair, reducing problems of tolerability and acceptability compared to synthetic 
materials [55].  
1.5.1 Biomaterials for Abdominal Wall Defects  
The birth of biologic materials, such as human decellularized dermal matrix (HDM), has 
changed the standard treatment of infected and/or complex abdominal wall defects.                                       
Nowadays, most reconstructions of these conditions are performed using biologic 
materials as the substrate for tension-free closure. A number of reports have 
documented the efficacy of HDM as a graft material for the repair of acquired 
abdominal wall defects, with promising results [56]. These biomaterials have been 
shown to become recellularized and revascularized in both animal and human subjects. 
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They contain collagen and elastin, hyaluronan, proteoglycans, fibronectin, the most 
important components of the extracellular matrix. In addition, HDM has the mechanical 
properties (i.e., tensile strength and elasticity) of a mesh for abdominal wall 
reconstructions. Nevertheless, once repopulated with a vascular network, the graft 
material is theoretically able to clear bacteria from the wound bed site through the 
release of inflammatory cells as well as nutrients and oxygen, a property not found in 
prosthetic graft materials. Finally, unlike autologous materials such as fascial grafts and 
muscle flaps, acellular dermal matrix can be used without subjecting the patient to 
additional morbidity in the form of donor site complications [57].  
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2. AIMS OF THE THESIS  
2.1 Differences in fibroblast extracellular matrices (ECMs) and their 
role in supporting keratinocytes growth and basement membrane 
formation 
After injury or in the case of a chronic skin wound, there are a number of biological 
products available on the market which promote healing. In particular, human 
decellularized dermal matrices (HDM) from cadaveric donor are now becoming more 
popular as a scaffold. The common feature of all these dermal scaffolds is that a high-
quality neodermis with randomly organized collagen bundles is regenerated.                   
However, these decellularized dermal scaffolds are commonly taken from reticular 
dermis rather than papillary dermis. Reticular dermis is much thicker than papillary 
dermis, and therefore provides a greater area for cell infiltration.                                                 
In addition, its relatively low cellularity in comparison to the papillary dermis means it 
is easy to decellularize. Lastly, the reticular dermis shows a strong mechanical 
resistance when compared to papillary dermis making it easy to handle. Despite these 
advantages, decellularized reticular dermis does not have a basal membrane and this 
feature can make re-epithelization of grafts by host keratinocytes cells more difficult.                                         
For these reasons, the problem of dermal scaffolds is they do not reflect the 
heterogeneity observed within the skin dermis, where different fibroblast sub-
populations, have divergent functions.  Furthermore, with decellularized scaffolds, in 
particular of animal origin, there can be issues associated with inflammation, and these 
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foreign body reactions have lead scientists to investigate new strategies based on in 
vitro organogenesis approaches.  A therapeutic strategy such as this requires cells to 
first be obtained from their native tissue, then kept in long term culture with appropriate 
growth factors to produce a tissue substitute rich in ECM.                                                         
Based on the above observations, I decided to investigate cell derived ECMs as 
potential scaffolds for use in skin tissue engineering. Thus, the two main objectives of 
this first part of the thesis were:  
1) to generate and biologically characterize cell-assembled ECMs produced by 
fibroblast sub-populations found both with the hair follicle dermis and the 
papillary and reticular dermis of human skin.  
2) to evaluate how ECMs from fibroblasts in different dermal locations, which are 
from areas juxtaposed to basement membrane, or devoid of basement 
membrane, can interact with and instruct basement membrane formation in 
epithelial only skin constructs. 
 
2.2 Investigation of Human Decellularized Dermal Matrix (HDM) 
regenerative ability in the reconstruction of Abdominal Wall Defects 
Human decellularized membranes are currently the subject of intense study, especially 
due to their ability to promote tissue regeneration. On this basis, the ideal scaffold for 
abdominal wall defects should be easily implanted with minimal patient morbidity, 
while assisting the long-term recovery of the tissue functionality.                                      
Moreover, the absence of inflammation, the quality of connective tissue organization, 
cellular repopulation as well as new tissue ingrowth and neo-angiogenesis represent 
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other features for the ideal scaffold for soft tissue regeneration.                                                       
To my knowledge, only animal studies investigated the in vivo biological interaction 
post-implant of scaffolds for soft tissue repair, while, it was noted the difficulty in 
obtaining a post-surgery biopsy specimens. In this respect, the success of the graft is 
usually established only by non-invasive analysis and functional outcomes measures. 
However, the post-implant evaluation would offer key information about the 
incorporation of the graft and the host cellular response in the human.  
Thus, the two main aims of this second part of the thesis were:  
1)  to show the clinical results obtained after the application of human 
decellularized dermal matrix, produced by RER Skin Bank, on patients suffering 
from different abdominal wall defects.  
2)  to evaluate the morphologic response at 1 year post implantation of human 
decellularized dermal matrix (HDM), through histological and ultrastructural 
analysis of biopsy specimens. 
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3. MATERIALS AND METHODS 
3.1 Differences in fibroblast extracellular matrices (ECMs) and their 
role in supporting keratinocytes growth and basement membrane 
formation 
3.1.1 Human tissue samples and cell culture 
Scalp skin tissue were taken from healthy donors using REC approved consent forms 
and used for the isolation of epidermal keratinocytes, and dermal sub-populations. 
Specifically, Pfi and Rfi were obtained from the upper and lower regions of 
interfollicular dermal tissue. Small pieces of superficial (papillary) and deep (reticular) 
dermis were minced, then placed in culture in different 35mm dishes in Dulbecco’s 
Modified Eagle’s Medium (DMEM) containing GlutaMAX (Gibco, Invitrogen) 
supplemented with 20% Fetal Bovine Serum (FBS) (Gibco, Invitrogen), 1% antibiotics-
antimycotics (Gibco, Invitrogen). Tissue were maintained at 37°C in a humidified 
atmosphere of 5% CO2/95% air for 10 days, during which time Pfi and Rfi migrated 
from their respected dermal explants. After migration of fibroblasts outward from the 
explants, cells were amplified in culture in DMEM GlutaMAX, 10% FBS and 1% 
antibiotics at 37°C in a humidified atmosphere of 5% CO2/95% air, and passaged until 
p3, at which time they were used to established cell derived ECMs. 
Intact dermal papillae were also isolated from the same piece of scalp skin, following a 
microdissection approach, to obtain DPfi cultures from the same donors as the Pfi and 
Rfi. Briefly, follicles were transected just above the level of the dermal papilla to isolate 
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end bulbs, which were inverted using 27G needles to remove the matrix and expose the 
dermal papilla. Papilla were then separated from the follicle by cutting through their 
stalk. For culture, 6–8 papillae were transferred to 35mm dishes containing 20% FBS in 
DMEM GlutaMAX, with 1% antibiotics-antimycotics. Cells migrated from the papillae, 
and when the dish was approaching confluence, DPfi were passaged at a 1:2 ratio using 
0.5% trypsin-edta (Gibco, Invitrogen) for detachment. After the initial 2 weeks of 
culture, cells were grown in DMEM GlutaMAX, 10% FBS and 1% antibiotics.                   
After passaging, DPfi were cultured in the same manner as Pfi and Rfi. Matched sets of 
cells, from 3 different donors were used for ECM generation and subsequent analysis. 
For keratinocyte isolation, skin samples were washed briefly in phosphate buffered 
saline (PBS) containing 2% antibiotics-antimycotics, then incubated in Dispase                            
(Stem Cell Technologies) overnight at 4°C. The epidermis and dermis were then 
separated from each other with fine forceps. Next, the epidermal layer was minced with 
scissors, and incubated in 0.5% trypsin-edta at 37°C for 30 minutes. Digested tissue was 
filtered through a 70μm cell strainer, then cells were pelleted and resuspended in Epilife 
medium (Gibco, Invitrogen) with 1% antibiotics and EDGS (Gibco, Invitrogen).                 
Cells were grown in a humidified atmosphere of 5% CO2/95% air and used for skin 
construct generation at P2.  
3.1.2 ECMs generation 
To generate ECMs from dermal fibroblast sub-populations we followed previously 
described protocols [58] (Figure 9). Sterile 13 mm glass coverslips in a 24 well-plate 
were coated with 0.2% sterile gelatin (gelatin type B, Sigma Aldrich) for 60 min at 
37°C. They were washed 3 times with PBS, cross-linked with 1% sterile glutaraldehyde 
(Sigma Aldrich) for 30 min at room temperature (RT) and again washed 3 times with 
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PBS. Crosslinking was quenched with 1M sterile glycine in PBS for 20 min at RT, 
followed by 3 more washes in PBS. Coverslips were then incubated in growth medium 
(DMEM GlutaMAX, 10% FBS, 1% antibiotics) for 30 min at 37°C.                                   
Finally, coverslips were washed 3 more times with PBS, then used immediately.                     
The three different sub-populations of fibroblasts (DPfi, Pfi, Rfi) were plated onto 
coverslips in 24 well plates. A total of 65,000 cells were seeded into each well in 
DMEM GlutaMAX, 10% FBS, 1% antibiotics and cultured overnight in 37°C, 5% 
CO2/95% air to achieve full confluency. The next day, growth medium supplemented 
with 50 μg/ml ascorbic acid (Sigma Aldrich) was added to each culture to promote self-
assembly of ECM. Medium was exchanged for fresh medium every two days for a total 
of ten days. After ten days of culture in ascorbic acid supplemented medium, cells were 
removed. Medium was aspirated and cells were washed once with PBS.                                          
Pre-warmed extraction buffer (20mM NH4OH, 0.5% Triton X-100 in PBS) was then 
added and left for 4 min to allow cell lysis. Half of the buffer was carefully removed 
and PBS was added. The same step was repeated until no intact cells were visible.                 
The DNA residue was digested with 10 μg/ml DNase I (Roche) in PBS for 30 min at 
37°C, 5% CO2, followed by two washes with PBS.  
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Figure 9: Protocol followed to generate ECMs from dermal fibroblast sub-populations. 
 
3.1.3 ECMs analysis 
Immunofluorescence staining and analysis of cell assembled ECMs 
I performed immunofluorescence of specific proteins in the self-assembled matrices 
using antibodies against individual ECM components. Matrices were fixed using 4% 
paraformaldehyde (PFA) for 20 minutes, followed by wash and blocking steps with 5% 
goat serum (Vector Laboratories) in PBS for 30 minutes. Primary antibodies (Table 1) 
were diluted in PBS and placed on matrices overnight at 4°C. Secondary antibodies 
(Table 1) were used for 1 hour at room temperature. Finally, they were washed 3 times 
in PBS and mounted on glass slides with Vectashield mounting medium (Vector 
Laboratories).  
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Antigen Source Species (raised in) Dilution used 
FIBRONECTIN Sigma-Aldrich Rabbit 1:500 
COLLAGEN 1 Abcam Mouse 1:300 
COLLAGEN 6 Abcam Rabbit 1:500 
TENASCIN C Abcam Mouse 1:300 
THROMBOSPONDIN Abcam Mouse 1:50 
Anti mouse-ALEXA 
fluor 488 
Molecular Probes Goat 1:200 
Anti rabbit-ALEXA 
fluor 546 
Molecular Probes Goat 1:200 
 
Table 1: Primary and secondary antibodies used for ECMs analysis. 
 
After staining, ECMs were imaged using a Zeiss LSM-510 inverted confocal 
microscope. Z-stack images of slices were acquired for each fibronectin stained sample, 
which were used for the evaluation of alignment and fiber measurements.                                 
Three random stacks were imaged per coverslip giving a total of nine images per cell 
donor. Moreover, the thickness of the ECMs was determined by taking a z-stack image 
on the confocal microscope and subtracting the distance between the top and the bottom 
of assembled fibronectin matrix. The images were subsequently processed with Image J 
and Fiji programs. Each z-stack set of images was converted to a single image by using 
the maximum projection function. The plugin dimensionality was applied to calculate 
the orientation distribution of the fibres, while the diameter of the fibres and 
interfibrillar spaces were assessed with the plugin BoneJ [59]. 
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ECM samples directly analyzed by mass spec        
The protocol I used for mass spectrometry was described previously by Plieger et al. 
[60]. After cell elimination, ECM proteins were directly proteolyzed in each well using 
2.5µg trypsin (Gibco, Invitrogen) in 250 µL of 30mM Tris (pH 8.0) at 37°C overnight. 
Predigested matrix proteins were scraped off from the wells using a cell scraper and 
collected into 1.5mL microfuge tubes. The samples were then reduced by the addition 
of DTT (final concentration 10mM) and incubated for 30 min at 56°C. After reduction, 
Iodoacetadime (IAM, final concentration 55mM) was added to keep the disulfide bonds 
separate and unfolded, and incubated for 30 min at RT in the dark.                         
Finally, the samples were further digested by trypsin at 37°C overnight before 
terminating the digest with the addition of 10% trifluoroacetic acid (final concentration 
0.5%). Samples were analysed by LC–MS using a nanoAcquity UPLC™ system 
(Waters MS Technologies, Manchester, UK). 1 μL (1-3 µg protein digest) of sample 
was injected onto each trapping column (Waters, C18, 180μm×20mm) using partial 
loop injection, for 1 min at a flow rate of 15μL/min with 0.1% (v/v) formic acid.                   
The sample was resolved on the analytical column (Waters, nanoACQUITY UPLC™ 
M-class HSS T3 75μm×150mm 1.8μm column) using a gradient of 97% A (0.1% (v/v) 
formic acid) 3% B (99.9% acetonitrile 0.1% (v/v) formic acid) to 60% A 40% B over 36 
min at a flow rate of 300nL/min. The nanoAcquity UPLC™ was coupled to a Synapt™ 
G2 mass spectrometer (Waters) and data acquired using a MSE program with 1s scan 
times and a collision energy ramp of 15–40eV for elevated energy scans.                                  
The mass spectrometer was calibrated before use and throughout the analytical run at 
1min intervals using the NanoLockSpray™ source with glufibrinopeptide.                       
Peptide identification was performed by using ProteinLynx Global SERVER™ v3.1 
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(Waters). The data was processed using a low energy threshold of 150 and an elevated 
energy threshold of 30. A fixed carbamidomethyl modification for cysteine was 
specified. The search thresholds used were: minimum fragment ion matches per peptide 
3; minimum fragment ion matches per protein 7; minimum peptides per protein 2 and a 
false positive value of 4. Data was searched against the most recent UniProtKB/Swiss-
Prot human database entry [61]. 
3.1.4 Generation of epidermal only skin constructs  
For this experiment, I used fibroblasts and keratinocytes as isolated in section 3.1.1.                                        
To start I placed several cell inserts (Millicell-24 Cell Culture Insert Plate, 
polycarbonate, 0.4µm) into a 60mm cell culture dish, and coated using the same method 
for coverslip coating as described in section 3.1.2. I seeded each fibroblast sub-
populations at a density of 30,000 cells/insert in DMEM GlutaMAX, 10% FBS, 1% 
antibiotics and allowed the fibroblasts to produce ECMs for 10 days in ascorbic acid 
supplemented medium on the inside of each insert. After removing fibroblasts, I seeded 
250,000 keratinocytes inside each insert on the top of the cell depleted ECMs, in Cnt 
Prime Medium (CellnTec). After 2 days, I removed the Cnt Prime Medium from the 
inserts and added 3D Barrier Medium (CellnTec) both inside and outside the inserts. 
The next day all 3D Barrier Medium was removed, and replaced with fresh 3D Barrier 
Medium on the outside of the inserts only. This enables establishment of an air liquid 
interface which is required for epithelial stratification. Finally, I kept the cells for 14 
days in culture at the air liquid interface, prior to analysis.  
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3.1.5 Skin constructs analysis: viability and basement membrane formation 
I used an alamar blue assay to assess cell viability of epidermal skin constructs after 14 
days of culture. Resazurin, the active ingredient of alamarBlue® reagent (Invitrogen), is 
reduced upon entering cells to resorufin, a compound that is red in color and highly 
fluorescent. Viable cells continuously convert resazurin to resorufin, increasing the 
overall fluorescence and color of the media surrounding cells.  Alamar blue dye at a 
concentration of 10% in PBS was added to each skin construct and incubated for 4 h at 
37 °C in 5% CO2/95% air. 100 μl of the medium was transferred to a fresh 96 well plate 
and absorbance was read at 570 nm. Data were expressed as an absorbance value unit. 
Alternatively, after the growth period of 14 days at the air-liquid interface, samples 
were snap-frozen in OCT mounting medium and stored at -80°C until processing. 
Frozen samples were sectioned into 7µm slides using a cryostat. For staining, these 
were fixed with either 4% PFA in PBS for 10 min at RT, or 100% methanol for 7 
minutes at -20C. After fixation, the samples were rinsed 3x with PBS and pre-treated 
for 30 min with PBS containing 5% goat serum, followed by incubation overnight at 
4°C with primary antibodies (Table 2). The sections were thoroughly rinsed with PBS 
and then incubated with secondary antibodies for 1hr at RT.                                            
Coverslips were mounted using Vectashield containing DAPI (Vector Laboratories), 
which subsequently labels nuclei. Confocal microscopy (Zeiss LSM-510 inverted) was 
used to visualize and capture immunostained cells.  
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Antigen Source Species (raised in) Dilution used 
LAMININ 5 R&D systems Mouse 10 µg/mL 
COLLAGEN 7 Abcam Mouse 1:500 
COLLAGEN 4 Abcam Mouse 1:50 
Anti mouse-ALEXA 
fluor 488 
Molecular Probes Goat 1:200 
 
Table 2: Primary and secondary antibodies used for Skin constructs analysis. 
 
For transmission electron microscopy, 14 days old constructs were fixed in 2.5% 
glutaraldehyde in 0.1 M cacodylate buffer at pH 7.2-7.4, washed in 0.1 M cacodylate 
buffer at pH 7.2, postfixed in 1% OsO4 in 0.1 M cacodylate buffer at pH 7.2, 
dehydrated in graded ethanol and embedded in Araldite (Serva). Ultrathin sections were 
counterstained with uranyl acetate and lead citrate and examined under a Zeiss EM109 
transmission electron microscope to evaluate basement membrane formation within the 
constructs. 
3.1.6 Graphs and statistical analysis 
All graphs were generated using GraphPad Prism version 6.01. Data are shown as the 
mean while error bars (±) are the standard deviation of the mean.  One-way ANOVA 
followed by Bonferroni’s correction was performed for experiments, with p <0.05 
considered significant.  
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3.2 Investigation of Human Decellularized Dermal Matrix (HDM) 
regenerative ability in the reconstruction of Abdominal Wall Defects 
3.2.1 Tissue procurement 
2-3 mm thick samples of human dermis were first taken from the backs of multi-organ 
and/or multi-tissue donors and then transported to the RER Skin Bank for processing 
according to national rules on tissues for transplantation (CNT 14/09/2016); here the 
tissues were aseptically decellularized and stored in nitrogen vapors (-180°C).                         
At 24 hours before surgical implantation, tissue samples of requested sizes were 
thawed, prepared and then sent in a sterile saline solution from the RER Skin Bank to 
Emergency Surgery and Trauma, of Bufalini Hospital and here conserved at a 
temperature of 4°C until its use.  
3.2.2 Patient population and surgical procedure      
Between June 2012 and December 2014, 64 patients, average age 64 years, received 
human decellularized dermal matrix (HDM) after signing consent forms, to replace and 
cover the damage area during abdominal wall defects surgery. Abdominal wall 
reconstruction was performed using the components separation technique by Ramirez et 
al. [62]. Briefly, this surgical technique is based on subcutaneous lateral dissection, 
fasciotomy lateral to the rectus abdominis muscle and dissection on the plane between 
external and internal oblique muscles with medial advancement of the block that 
includes the rectus muscle and its fascia. This release permits medial advancement of 
the fascia and a closure up to 20 cm wide defects in the midline area. Then HDM was 
positioned in a bridge onlay technique in aseptic conditions and then it was sutured 
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(Figure 10A). Finally, the incision was then dressed with a negative pressure wound 
therapy dressing (Figure 10B).  
 
 
 
Figure 10: Digital photographs illustrating surgical technique used by the surgeons.                                              
(A) Bilateral release of the external oblique muscles allowed for a tension-free fascial closure of 
this large deficit. Then a sheet of decellularized human dermis was placed as an overlay 
reinforcement and sutured. (B) The incision was finally dressed with a negative pressure wound 
therapy dressing. 
 
 
The number and the size of the drains varied based on the size of the overlying skin 
flaps. In the case of large abdominal wall defects (Figure 11A), multiple pieces of 
human decellularized matrix were sutured together on the operating table and were inset 
to the fascial edges (Figure 11B). 
  
 
 
Figure 11: Digital photographs illustrating one case with large deficit from the series. (A) Large 
abdominal wall defects. (B) Multiple pieces of decellularized human dermis were sutured 
together and were inset to  the fascial edges. 
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After surgical procedures, all patients were followed weekly for the first month and then 
monthly up to 6 months postoperative and any major problem or complication were 
recorded. Six months follow up included abdominal exams, serological tests for the 
potential detection of HBV, HCV and HIV virus and magnetic resonance imaging 
(MRI) analysis in order to evaluate integration of HDM with the patient’s surroundings 
tissues and eventual long-term complications.  
3.2.3 Histological and ultrastrucutural analysis of HDM biopsy specimens  
Biopsy specimen’s collection 
Biopsy specimens were taken after signing consent forms from 3 patients, 1 female and 
2 males (average age 60 years), suffering from recurrent hernia at 1 year after the first 
abdominal wall reconstruction. The initial repair used a 2-3 mm thick HDM taken from 
the backs of 3 different tissue donors, processed and stored until its use at the RER Skin 
Bank, following the surgical technique described above. One year later, all the 3 
patients developed another hernia in a different abdominal area. During the second 
surgery, it was evident that the HDM previously transplanted was well incorporated by 
the surrounding tissues without any sign of inflammation. Thus, biopsy specimens of 
human decellularized dermis were taken from the previously transplanted area (different 
parts as transplant mapping). 
Histological analysis 
Biopsy specimens were fixed in 10% neutral buffered formalin and embedded in 
paraffin. Five to seven µm paraffin sections were stained with hematoxylin and eosin 
(H&E), Masson’s trichrome and Weigert for morphological, collagen and elastic fibers 
analysis respectively. As control the same unimplanted HDM was prepared and stained 
following the same protocol. Semiquantitative histometric analysis was performed and 
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included evaluation of the amount of cellular infiltration, the presence of multinucleated 
giant cells, new blood vessels formation, the degree of the connective tissue 
organization. For the histometric analysis, we followed the methods described by 
Valentin JE et al., 2006 [63] (Table 3). A pathologist examined all the slides and then 
assigned scores on four selected fields at the same magnification (40X) for each 
patient’s slide. 
 
Table 3: Scoring Criteria of the Semiquantitative Histometric Analysis. At forty times 
magnification the analysis were based on 4 selected fields/ patient’s slide [63]. 
 
Ultrastructural analysis 
Biopsy specimen fragments were fixed in 2.5% glutaraldehyde in 0.1 M cacodylate 
buffer at pH 7.2-7.4, washed in 0.1 M cacodylate buffer at pH 7.2, postfixed in 1% 
OsO4 in 0.1 M cacodylate buffer at pH 7.2, dehydrated in graded ethanol and embedded 
in Araldite (Serva). Ultrathin sections were counterstained with uranyl acetate and lead 
citrate and examined under a Zeiss EM109 transmission electron microscope, to 
evaluate the ultrastructural dermis organization both at cellular and stromal level.  
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41 
 
4. RESULTS AND DISCUSSION 
4.1 Differences in fibroblast extracellular matrices (ECMs) and their 
role in supporting keratinocytes growth and basement membrane 
formation 
In the last two decades, the key role of ECM in cell biology has become more evident. 
Indeed, ECM is known to regulate cell behaviour, and it plays an essential role during 
organ development, function and repair [64]. On this basis, ECM as a molecular 
scaffold is fundamental for tissue homeostasis and alterations in a specific ECM 
component can lead to disruption of this process [65]. Physical properties such as 
topography and porosity of ECM can influence various anchorage-related biological 
functions such as cell division and migration [66]. Given the importance of ECM in cell 
biology, ECM scaffolds are starting to become commonplace for tissue repair [67]. 
However, within the skin at least, dermal replacements used to promote regeneration are 
insufficient. They are composed of only a simple ECM, or decellularized reticular 
dermis, and they do not take into account the heterogeneity within whole skin dermis 
[2]. These limitations highlight the need for bioinspired scaffolds for skin repair.                 
ECM scaffolds derived from cultured cells offer several advantages compared with 
decellularized tissues; there are lower risks of pathogen transmission and undesirable 
inflammatory and immunological reactions [68]. 
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4.1.1 ECMs thickness and morphology   
I first generated cell assembled matrices from each of the three fibroblast                                
sub-populations; DPfi, Pfi and Rfi. Using confocal microscopy images of 
FIBRONECTIN (FINC) coupled with image analysis algorithms we found that the 
composition, morphology and architectural structure of the self-assembled ECMs varied 
between each of the three fibroblast sub-populations used (Figure 12 A-C).      
Specifically, Pfi generate matrices with significantly thicker fibres than DPfi and Rfi, 
which are associated with lowest amount of interfibrillar space between each fiber                        
(Figure 12 D, E). The fact that Pfi generate matrices with significantly thicker fibres 
than DPfi and Rfi is different to ECM organization in vivo, where the papillary dermis 
contains thinner fibers than the reticular dermis [5]. However, with regards to 
organization, we observed parallels in our cell assembled ECMs, to ECM in different 
locations within the skin dermis in vivo. In fact, Pfi derived ECM fibers were 
significantly anisotropic compared to both Rfi and DPfi derived matrices (Figure 12 F). 
This bears resemblance to the papillary dermis, which is disorganised in comparison to 
the reticular dermis [5]. Lastly, when we assessed matrix thickness, the DPfi deposited 
significantly more matrix than both Rfi and Pfi (Figure 12 G). In fact, in the hair follicle 
a thick basement membrane, termed a glassy membrane, separates the dermal papilla 
from the surrounding epithelial matrix [69]. 
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Figure 12: Morphological characterisation of cell assembled ECMs. Phase contrast images of 
cells, and representative immunofluorescence images of FIBRONECTIN (FBN) stained ECMs 
generated by DPfi (A), Pfi (B) or Rfi (C) after 10 days in culture. 
 
4.1.2 ECMs composition 
Given the different fiber morphologies in our cell assembled ECMs from different 
fibroblast sub-populations, we wanted to determine whether there were differences in 
matrix composition. To do this, we performed mass spectrometry analysis of digested 
matrix proteins. The analysis identified different proteins in the range of 800-4000 
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Dalton. In total, 13 extracellular matrix proteins were identified within the DPfi, Pfi and 
Rfi cell assembled ECMs (Table 4).  
  
Protein Matched Peptide IntenSum 
Protein 
Protein 
avgMass 
DPfi Pfi Rfi 
FINC_ 
HUMAN 
266217,54 9163420 5802190,8 7403315,84 
COL1A1_ 
HUMAN 
139968,14 463655,5 --  52381,07 
COL1A2_ 
HUMAN 
129827,27 219029 -- --  
COL6A1_ 
HUMAN 
109670,06 1337386 118216 221323,57 
COL6A2_ 
HUMAN 
109777,13 758071,5 -- --  
COL6A3_ 
HUMAN 
345380,56 3940456 242998,8 856061,15 
TNC_ 
HUMAN 
246499,36 1674585,5 876852,2 1101812,47 
TSP1_ 
HUMAN 
133374,73 475685,8 -- 141405,50 
VTNC_ 
HUMAN 
132332,61 12644,1 --  --  
FBLN2_ 
HUMAN 
334344,74 147845,5 85106,7 245734,33 
VIME_                                                          
HUMAN 
53708,79 123973 --  --  
FBN1_ 
HUMAN 
332881,9 --  --  299088  
EMIL1_ 
HUMAN 
107978,8 --  --  46777 
 
Table 4: Mass spectrometry data showing proteins detected from different fibroblast             
cell-assembled ECMs; protein avg mass is the average mass of the protein and peptide intensity 
sum is a sum of all the peptide fragments for each protein that the machine detected. 
 
Specifically, FIRONECTIN and TENASCIN (TNC) were produced by all three 
different fibroblasts subpopulations. Intriguingly, alpha 1 chain COLLAGEN 1 
(COL1A1), which is generally thought to be expressed throughout the dermis, was not 
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detected in Pfi ECM. We found that while alpha 1 chain COLLAGEN 6 (COL6A1) and 
alpha 3 chain COLLAGEN 6 (COL6A3) were present in all ECMs derived from all cell 
types, alpha 2 chain COLLAGEN 6 (COL6A2) was predominantly found in the DPfi 
ECM.  TSP1, VITRONECTIN (VTNC), FIBULIN 2 (FBLN 2), VIMENTIN (VIME), 
FIBRILIN 1 (FBN 1) and EMILIN 1 (EMIL 1) were also only detected in DPfi or Rfi 
ECM. Interestingly, it’s possible to classify the identified proteins, according to the 
type, in 4 groups: collagens (alpha 1 and 2 chain of COLLAGEN 1 and alpha 1, 2 and 3 
chain of COLLAGEN VI); adhesion proteins (FIBRONECTIN and VITRONECTIN); 
cellular proteins (VIMENTIN) and other ECM proteins (TENASCIN C, 
THROMBOSPONDIN, FIBULIN 2, EMILIN 1 and FIBRILIN 1). It’s worth 
mentioning the absence of COLLAGEN 3, ELASTIN, glycosaminoglycans (GAG’s) 
and hyaluronic acid (HA), which are usually key components of ECMs [70]. This could 
be due to limit of detection of the mass spectrometer but also for the relative short time 
of fibroblasts culture to deposit ECMs. Firstly, the complex overlap between protein 
spectra makes for difficult analysis: database searches are not perfect at identifying 
proteins, and in some cases may falsely identify a protein [71]. Instead, in order to 
support the hypothesis of early ECMs, I want to highlight the presence of fibrilin 1.                 
In fact, the elastic fibers are composed by a central elastin core covered by a sheath of 
microfibrils, consisting of different glycoproteins including fibrilin 1. During embryonic 
development, microfibrils appear before elastin and form a scaffold on which elastin is 
deposited [72]. In addition, to verify that proteins detected in mass spectrometry 
analysis were expressed within our cell derived ECMS, I stained each cell assembled 
ECM with antibodies against COL1 (all chains), COL6 (all chains), TNC and TSP1.                           
Despite not finding COL1A1 in our Pfi ECM, COL1 was present in all samples                         
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(Figure 13 A). Likewise, TNC was present at similar levels across all cell derived 
ECMs (Figure 13 B). The COL6 antibody detected all alpha chains and we found equal 
expression in all our ECMs (Figure 13 C), however, TSP1 was predominantly expressed 
in DPfi derived matrix (Figure 13 D). We used image analysis to quantify expression 
levels, and confirm these observations (Figure 13E-H). These results both confirm our 
mass spectrometry data, and corroborate previous reports, in which TSP1 was estimated 
to be more abundant within the dermal papilla, as appose to the interfollicular skin 
dermis [73].  
 
Figure 13: ECMs composition.  Representative immunofluorescence images of COL1 (A), 
COL6 (B), TNC (C) and TSP1 (D) in ECMs generated by DPfi, Pfi or Rfi cells after 10 days in 
ascorbic acid supplemented medium. Quantification of immunofluorescence is plotted in graphs 
(E-H) (n=3 experiments, 9 images per experiment). *p<0.05, **p<0.01. Scale bars: 50 µm.  
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To conclude, the composition of cell assembled ECM in vitro is also similar to the ECM 
in the spatial locations from where the cells were derived. In particular, TSP1 was 
preferentially deposited by DPfi, while the in vivo dermal papilla is rich in TSP1.                  
The dermal papilla has a critical role in the regulation of hair growth [74], as compared 
to reticular or papillary dermis [73], which do not express TSP1.  
 
4.1.3 Skin constructs analysis 
After determining that ECMs could be successfully generated from each fibroblast 
subtype, we decided to employ a protocol to generate epithelial only skin constructs, 
replacing the collagen coating which is usually used with ECM assembled from each 
cell type. Using alamarBlue to assess keratinocyte viability, we found no significant 
statistical differences between epithelial only constructs grown on different self-
assembled ECMs compared to the control (Figure 14 A). 
 
Figure 14: Epithelial only skin constructs grown on cell assembled ECMs. (A) Viability assay 
of cultured keratinocytes on different fibroblast derived matrices (mean ± standard deviation). 
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Next, we specifically wanted to assess basement membrane formation, since our 
fibroblast sub-populations were derived from sub-anatomical locations subjacent to, and 
devoid of basement membrane. We used antibodies against LAMININ 5 (LAMA5), 
COLLAGEN 4 (COL4) and COLLAGEN 7 (COL7) to assess basement membrane 
characteristics. LAMA5, and COL4, which are deposited from both fibroblasts and 
keratinocytes [75], were observed only in the constructs grown on Pfi ECM, DPfi ECM 
and in the control group (Figure 15 and 16 A,B,C).  On the contrary, we were unable to 
find either of these proteins in constructs supported by Rfi (Figure 15 and 16 D).  
 
Figure 15: Immunofluorescence images of LAMA5 in epithelial only constructs cultured on 
coating matrix (A), or DPfi (B), Pfi (C) and Rfi (D) derived ECM. (n=3) Scale bars: 50µm. 
 
 
Figure 16: Immunofluorescence images of COL4 in epithelial only constructs cultured on 
coating matrix (A), or DPfi (B), Pfi (C) and Rfi (D) derived ECM. (n=3) Scale bars: 50µm. 
 
COL7, whose production in keratinocytes is stimulated by fibroblasts, was found in 
both DPfi and Pfi matrix supported constructs (Figure 17 B, C). However, COL 7 was 
not expressed in the control group (epithelial constructs on coating only), or in the Rfi 
ECM supported constructs (Figure 17 A, D).  
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Figure 17: Immunofluorescence images of COL7 in epithelial only constructs cultured on 
coating matrix (A), or DPfi (B), Pfi (C) and Rfi (D) derived ECM. (n=3) Scale bars: 50µm. 
 
This observation is supported by previous studies, where authors not only found more 
COL7 production and deposition by fibroblasts in comparison to keratinocytes, but also 
observed that decellularized fibroblast ECM stimulated the production and deposition of 
COL7 by keratinocytes [76].                                                     
In addition to immunofluorescence, we used transmission electron microscopy to assess 
the basement membrane formation in our epithelial only skin constructs. Basement 
membranes could be detected in the control group, and in skin supported by Pfi and 
DPfi matrices, but not Rfi derived matrices. The skin constructs grown on Pfi matrices 
had a very clear and continuous basal lamina structure compared to the control. In 
contrast, the skin constructs supported by DPfi derived ECM had a very thick basement 
membrane; however, this was not continuous across the entire construct (Figure 18 A). 
Finally, transmission electron microscopy showed that in constructs supported by all 
three ECM types, numerous desmosomes (Figure 18 B) were linking cells throughout 
the basal and suprabasal layers of the epidermis suggesting normal differentiation and 
stratification. 
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Figure 18: Ultrastructural analysis of the basement membrane (arrows) (A) and desmosomes 
(brace) (B) in the epithelial only skin constructs. (n=3)  
Scale bars for A: 0,2µm and for B: 0,1 µm. 
 
It is well known that the skin dermis and its interaction and crosstalk with epithelial 
cells is important for the production of the basement membrane components [77].                                     
Refocusing on constructs supported by Rfi matrices, I found no evidence of basement 
membrane establishment with either antibody staining or transmission electron 
microscopy. This is despite basement membrane formation occurring within our control 
samples and suggests that there may be an inhibitor of membrane formation within the 
Rfi matrices [13]. While I removed cells from our matrices, growth factors would 
remain attached to the ECM. I therefore cannot conclude that this observation is due 
specifically to the different ECMs, and it is highly likely that the growth factors 
constituents produced by the different fibroblast sub-types play an important role 
directing the establishment of a basement membrane [78]. Interestingly, when Pfi and 
Rfi are grown in co-cultures with keratinocytes, they form cysts [5].                                
The Rfi-keratinocyte cysts do express LAMA5, however COL7 is absent.                            
This is in contrast to Pfi-keratinocyte cysts which express all basement membrane 
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components [5]. This again reflects the dermal locations of the cells in vivo, where 
supporting establishment of a basement membrane is not a part of their repertoire.                     
In contrast, DPfi support establishment of a very thick basement membrane, reflecting 
their location subjacent to a thickened basement membrane termed a glassy membrane 
in vivo [69]. It is postulated that the expression of LAMA5 and COL7 in the hair 
follicle basement membrane is necessary for maintaining the structural integrity of the 
dermal papilla [13].  
 
4.2 Investigation of Human Decellularized Dermal Matrix (HDM) 
regenerative ability in the reconstruction of Abdominal Wall Defects 
Several studies have demonstrated that human decellularized dermal matrices may 
achieve excellent results in the treatment of contaminated and complex abdominal wall 
defects [53]. In fact, it is now well documented that human decellularized matrix has 
been shown to be associated with lower rates of infection, extrusion, erosion, and 
adhesion formation compared with synthetic mesh [79]. Specifically, to our knowledge, 
for the first time a non-commercial decellularized dermis produced by a Skin Bank was 
implanted to close abdominal wall defects. Moreover, this is the first study of 
postoperative human biopsy specimens of decellularized human matrix used for hernia 
repair. 
4.2.1 Patients clinical follow–up 
A total of 64 patients, 30 females and 34 males, suffering from abdominal wall defects 
underwent to surgical operation with implantation of decellularized human dermis. 
Human decellularized dermal matrix was used for patients with different clinical 
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conditions, such as incisional hernia, Hartmann recanalization, post-traumatic wounds, 
abdominal tumor, umbilical hernia and rectovaginal fistula. In particular, incisional 
hernia was the most frequent clinical condition in which HDM was applied, as shown in 
Table 5, requiring also the highest amount of human decellularized dermis to repair 
abdominal wall with an average size of 186,5 cm2.  
 
Clinical indications 
Number of 
patients 
Mean size of 
decellularized 
dermis 
transplanted (cm2) 
Incisional hernia 
40 186,5 
Hartmann recanalization 
7 76,8 
Post-traumatic wounds 
6 120 
Abdominal tumors 
4 125 
Umbilical hernia 
4 92,2 
Rectovaginal fistula 
3 52 
                       
Table 5: Clinical Indications for use of human decellularized dermis, number of patients treated 
and average size of the tissue graft.  
 
 
One month after the surgical operation, 61 patients revealed a well tolerability of HDM 
and a normal wound healing was also identified in all the damage areas. Only 3 patients 
(4,7%) experienced postoperative infections that were treated with appropriate antibiotic 
therapy without removal of the HDM. Moreover, the follow up after 6 months reported 
no signs of dermis rejection and that none of the patients was positive to serological 
tests, even if the risk of transmitting infectious diseases is extremely low, because of 
strict human donor control as well as physical and chemical treatments when processing 
and storaging the tissue. Figure 19 depicts the clinical case a 52 years male suffering 
from incisional hernia (Figure 19 A), that was treated with 3 different sheets of human 
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decellularized dermis for the reconstruction of abdominal wall, using components 
separation technique (Figure 19 B). After 1 month, the patient demonstrated a total 
recovery of the damage area (Figure 19 C) and after 6 months follow-up, MRI analysis 
demonstrated an intact abdominal cavity with no evidence of hernia and a perfect 
incorporation of the HDM in the patient surrounding tissues (Figure 19 D). Similar 
results were also obtained in all patients after MRI analysis, confirming the integration 
of HDM on the lesion area with the abdominal wall tissues.  
 
Figure 19: (A) Male patient with ventral hernia. (B) Intraoperative view of human 
decellularized dermis. (C) One month postoperative view of patient following abdominal wall 
reconstruction. (D) Six-month follow-up using MRI analysis. 
 
Further only few patients developed long term complications such as seroma, as 
reported in Table 6. Differently from other clinical studies, in which a recurrence hernia 
frequently occurred, we identified it only in 1 patient. This can be due to the thickness 
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of our scaffold, which can increase the strength of the tissue graft reducing the 
recurrence rate. In fact it was suggested that the use of thicker products can prevent 
stretching of the material over time [80]. Moreover it is worth mentioning the absence 
of post-implant infections in long-term follow-up, while several studies have 
demonstrated that animal HDMs could often become infected, resulting in the removal 
of them [81]. This is due to the fact that this animal tissues are not processed and treated 
in clean rooms, in compliance with all GMPs standards.  
 
 
 
 
 
 
 
Table 6: Long-term complications after MRI analysis. 
 
4.2.2 Histological and ultrastructural findings of  HDM biopsy specimens 
Light microscopy findings   
The HDM pre-transplant was characterized by a dense, acellular, haphazardly structured 
collagen matrix (Figure 20 A and B), without blood vessels. Moreover, by the use of 
Weigert staining, numerous randomly disposed elastic fibers were identified                        
(Figure 20 C), which appeared disrupted, likely due to decellularization process. After 
one year, the HDM biopsy specimens showed numerous fibroblasts and an extensive 
neoangiogenesis (Figure 20 D in the middle). The graft presented highly oriented 
6-months follow-up: results 
Number of 
patients 
Perfect integration of the graft 
with the host tissue 
55 
Seroma 4 
Laxity 3 
Recurrence 1 
Incisional hernia in a different area 1 
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collagen pattern as in a normal dermal tissue (Figure 20 E). The elastic fibers were thin 
and parallel to collagen fibers (Figure 20 F).  
 
 
Figure 20: Histological comparison between pre-transplant and biopsy specimen HDM. The 
HDM pre-transplant was decellularized (A) (H&E staining, 10x), characterized by haphazardly 
structured collagenous fibers (B) (Masson Trichrome staining, 10x) and by numerous disrupted 
elastic fibers (C) (Weigert staining, 10x). The HDM biopsy specimens showed extensive 
fibroblast infiltration with numerous new blood vessels (D) (H&E staining, 10x), highly 
oriented collagen pattern (E) (Masson Trichrome staining, 20x) and thin elastic fibers parallel to 
collagen fibers (F) (Weigert staining , 20x).  
 
Hypertrophic fibroblasts were present in a small area where the collagen matrix was still 
in remodeling, as a sign of tissue regeneration (Figure 21 A). Only few inflammatory 
cells were present at the periphery of the HDM biopsy specimens. Only in patient 2, a 
typical foreign-body tissue response was present, including few multinucleated giant 
cells around blood vessels (Figure 21 B).  
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Figure 21: H&E stainings HDM biopsy specimen of patient 2, 20X. Hypertrophic fibroblasts 
(arrow) in a small area where the collagen matrix was still in remodeling (A). A multinucleated 
Giant’s cell (arrow) around blood vessels as a typical foreign-body tissue response (B). 
 
 
In addition, a histological comparison of HDMs pre-transplant (taken from 3 different 
tissue donors) was also performed in order to compare the matrix differences before 
transplant (Figure 22 A, B, C). All the HDMs pre-transplant were well decellularized, 
but the HDM of donor 2 appeared to be less dense compared to the others two (Figure 
22 B).  
 
Figure 22: Histological comparison between pre-transplant HDM in donor 1 (A), 2 (B) and 3 
(C) respectively. (H&E staining, 10x). The HDM pre-transplant were decellularized, 
characterized by haphazardly structured collagenous fibers. The HDM of donor 2 appeared to be 
less dense compared to the others two. 
 
 
Morphometric analysis findings  
The mean scores for the three patients are presented in Table 7. The patient 2 showed 
the most intense immune response, as assessed by the presence of inflammatory cells 
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and multinucleated giant cells at the implant site. Blood vessels were also detected in all 
the implants, while the patient 3 revealed the best connective tissue organization. 
Taking into account the HDM pre-implant characteristics (Figure 22), a relationship 
between inflammatory cells and collagen remodeling seemed to be; indeed, the more 
inflammatory infiltrate was abundant, the organization of connective tissue resulted 
more improved.  
 
 
Table 7: Semiquantitative Morphometric Analysis. Mean scores for each patient’s slide                    
(four fields at 40x magnification analyzed). The scores for each implant were tabulated 
according to the criteriain table 6.  
 
 
Ultrastructural findings      
TEM analysis confirmed histological data. In particular, fibroblast cells showed typical 
elongated shape with normal nuclei (Figure 23 A): few collagen fibers were seen in the 
fibroblast cytoplasm suggesting their active synthesis (Figure 23 B). Collagen fibers 
were characterized by a normal morphology and band size (Figure 23 C). The vascular 
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structures lined by endothelial cells and smooth muscle cells showed normal 
morphology (Figure 23 D). 
 
Figure 23: Ultrastructural analysis of HDM biopsy specimens: long-shaped fibroblasts (A) 
(scale bar 0,2µm) producing a collagen fiber (arrow) (B) (scale bar 0,5 µm) and normal 
morphology of collagenous structure (C) (scale bar 2 µm); finally, a normal blood vessel (D) 
(scale bar 0,2 µm). 
 
The histological and ultrastructural results from this study support previous preclinical 
conclusions concerning the HDM produced by RER Skin Bank reported by Bondioli et 
al. [36]. Overall, the RER Skin Bank HDM, transplanted in patients suffering from 
abdominal hernia, was characterized by cellular repopulation, neoangiogenesis, minimal 
inflammatory response and a well-organized collagen matrix in all biopsy specimens 
investigated. In particular, it is well known that natural collagen remodeling is 
performed through the coordinated enzymatic actions of assorted matrix 
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metalloproteinases (MMPs) [82]. The minimal inflammation is very important, because 
host immune cells rapidly infiltrate the graft and facilitate the degradation and the 
remodeling of HDM [83]. Moreover, it is worth mentioning the correlation between the 
morphology of HDM pre-implant related to donor age, the inflammatory response and 
the connective tissue remodeling after one year. These findings showed that the HDM 
owns pivotal still undefined biologic factors, activating the tissue regeneration process. 
It has been reported that the degradation products of extracellular matrix (ECM) have a 
key-role in tissue regeneration, likely due to their chemoattractive effect on endothelial 
cells, bone marrow derived cells and mesenchymal stem-cells [84]. In addition, HDM 
bioactivity is also confirmed by growth factors maintenance in the acellular ECM, 
which are responsible for cell recruitment, proliferation, angiogenesis and tissue 
regeneration  [85]. Considering the criteria for a functional implant [41], it is evident 
that the HDM can be considered a promising biomaterial for hernia repair representing 
an inductive template  for remodeling with host tissue.                                                                              
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5. CONCLUSIONS 
 
This PhD thesis deals with the very important issue of the extracellular matrices 
(ECMs) in the field of skin tissue engineering. Considering the great interest towards 
ECM to better understand fundamental tissue processes, several tissue-culture models 
have been developed to study the interplay between its biochemical and biophysical 
properties, and to understand the molecular origins of cellular behaviors regulated by 
ECM ligation [18]. For instance, synthetic matrices have been developed with well 
defined fibers organization and stiffness, using biomaterials as polyethylene glycol 
(PEG) hydrogels [86]. Although these matrices can be covalently modified with ECM 
ligands and growth factors [87], they do not resemble to the organizational features of 
native collagen and often their pore sizes strongly impede cell migration.                                 
To overcome this issue, biomaterial specialists have created decellularized ECM 
scaffold from various tissues, but in particular for those deriving from animal tissues 
there might be problems associated with inflammation and rejection [88]. For these 
reasons, scientists investigated new strategies based on in vitro organogenesis 
approaches [67]. ECM produced by cells, via a self-assembly approach, has been shown 
to act as a key cell adhesion site and a mechanically strong scaffold free support for 
tissue engineering [89].  
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 In the first part, I proposed a new approach to produce ECMs based on the concept of 
organogenesis, starting from different fibroblast subpopulations within the skin dermis. 
I kept fibroblasts in long term culture with appropriate growth factors to produce a 
tissue substitute rich in ECM and then after the ECMs characterization, I created 
epithelial only skin construts. The results showed that the composition, fiber 
morphology, and behavior between the different cell derived ECMs varied between 
each of the three fibroblast sub-populations used. These differences, I observed, reflect 
differences that are physiologically present between the papillary, reticular, and hair 
follicle dermis within the skin [5]. The cell-assembly approach might also be used to 
establish ECM of different thicknesses and strengths, keeping for longer time cells in 
culture and adding different growth factors [90]. Moreover, I also demonstrated that 
matrices derived from both DPfi or Pfi could be superior to Rfi derived dermis as an 
effective product for skin engineering. In fact, Pfi and DPfi support establishment of a 
well formed basement membrane, reflecting their location subjacent to a thick basement 
membrane in vivo [91]. I believe that inspiration can be taken from these 
physiologically different cell-derived ECMs, to improve the design of reliable 
biomimetic materials with therapeutic potential for skin tissue engineering.                                     
In the second part, indeed, I presented the excellent results obtained after the clinical 
application of HDM in patients suffering from abdominal hernia.                                       
Several clinically approved decellularized matrices are regularly applied in vivo, 
primarly as tissue fillers with safe outcomes [92]. However, there are studies which 
reported negative clinical results with some of these commercial products. For instance, 
it has been shown that porcine small intestinal submucosa (SIS) is associated with 
complications after implantation. In general these complications included lack of tissue 
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repopulation and blood vessel infiltration, with high levels of fibrosis in the periphery of 
the implanted material [93]. In this respect, despite numerous clinical experiences, 
mechanisms of biomaterial integration with human tissues, and rejection responses in 
some cases, remain unexplained and poorly dissected. Conversely, the HDM produced 
by RER Skin Bank not only provided excellent clinical outcomes in the long-term 
follow up, but also biopsy specimens post-implant showed that HDM has adequate 
properties to regenerate into functional tissues. I think one of the key features is that it 
has human origin. Then a careful screening of cadaveric donors is required by National 
Center for Tissue Transplantation, in order to avoid transmission of infectious diseases. 
Moreover this tissue is submitted to an ideal decellularization process, which can 
remove all cellular components, while maintaining natural ECM structure and 
composition [36]. The result is a perfect integration with the surrounding without any 
sign of rejection and fibrosis in the periphery of the implanted material.                               
Finally compared to commercial products HDM hasn't a high cost, since it derives from 
human donation. To conclude this second part showed an effective HDM product in the 
field of soft tissue repair, adding also relevant data that can serve as reference to 
establish new decellularized biomaterials technologies.  
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